Learn more about this affordable cancer screening test from idexx. The element i+ immunodiagnostic analyzer supports diagnostic needs with the following tests Canine cancer, t4, ctsh, cortisol, progesterone, and ccrp Introducing the nu.qtm vet cancer screening test for pet owners cancer is the most common cause of death in dogs over the age of 2 years in the us. The nu.q canine cancer screening test, a diagnostic product manufactured by volition, is now available through idexx's u.s Among the detected cancers are lymphoma, hemangiosarcoma and.
The nu.q cancer screen test is a relatively new blood test for dogs to check for the 7 most common canine cancers. Introduce nu.q ® vet into your clinic our test is currently available in the united states, europe, australia, and asia through reference laboratories which include idexx and heska/antech You can find details of your local distributor below. Volition, a multinational epigenetics company, announced today the availability of its nu.q vet cancer test through the idexx reference laboratory network in the us 1 tom butera, dvm, chief executive officer of volition veterinary diagnostics development llc, said Idexx is a global leader in.
Don't let canine cancer go unchecked Talk with your veterinarian about the idexx nu.q® canine cancer screen—a new way to identify dogs at risk for cancer.
OPEN
